Myo Maung Maung Swe1,2, Elizabeth A Ashley1,3, Thomas Althaus2,4, Yoel Lubell2,4, Frank Smithuis1,2,5, Alistair R D Mclean1,2. 1. Myanmar Oxford Clinical Research Unit, Yangon, Myanmar (MOCRU), Yangon, Myanmar. 2. The Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK. 3. Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Vientiane, Laos. 4. Mahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. 5. Medical Action Myanmar, Yangon, Myanmar.
Abstract
BACKGROUND: Most antibiotic prescribing occurs in primary care. Even within the same health facility, there may be differences between prescribers in their tendency to prescribe antibiotics, which may be masked by summary data. We aimed to quantify prescriber variability in antibiotic prescription to patients with acute fever in primary care clinics in Myanmar. METHODS: We conducted a secondary analysis of prescribing data from 1090 patient consultations with 40 prescribing doctors from a trial investigating the effect of point-of-care C-reactive protein (CRP) tests on antibiotic prescription for acute fever. We used multilevel logistic regression models to assess inter-prescriber variability in the decision to prescribe antibiotics. RESULTS: The median odds ratio (MOR) in the unadjusted model was 1.82 (95% CI: 1.47-2.56) indicating that when two prescribers from this population are randomly selected then in half of these pairs the odds of prescription will be greater than 1.82-fold higher in one prescriber than the other. The estimated variability from this sample of prescribers corresponds to a population of prescribers where the top 25% of prescribers will prescribe antibiotics to over 41% of patients while the bottom 25% will prescribe antibiotics to less than 23% of patients. Inter-prescriber variation in antibiotic prescribing remained after adjustment for patient characteristics and CRP information (P < 0.001). CONCLUSIONS: Despite sharing the same management guidelines, there was substantial inter-prescriber variation in antibiotic prescription to patients with acute fever. This variation should be considered when designing trials and stewardship programmes aiming to reduce inappropriate antibiotic prescribing.
BACKGROUND: Most antibiotic prescribing occurs in primary care. Even within the same health facility, there may be differences between prescribers in their tendency to prescribe antibiotics, which may be masked by summary data. We aimed to quantify prescriber variability in antibiotic prescription to patients with acute fever in primary care clinics in Myanmar. METHODS: We conducted a secondary analysis of prescribing data from 1090 patient consultations with 40 prescribing doctors from a trial investigating the effect of point-of-care C-reactive protein (CRP) tests on antibiotic prescription for acute fever. We used multilevel logistic regression models to assess inter-prescriber variability in the decision to prescribe antibiotics. RESULTS: The median odds ratio (MOR) in the unadjusted model was 1.82 (95% CI: 1.47-2.56) indicating that when two prescribers from this population are randomly selected then in half of these pairs the odds of prescription will be greater than 1.82-fold higher in one prescriber than the other. The estimated variability from this sample of prescribers corresponds to a population of prescribers where the top 25% of prescribers will prescribe antibiotics to over 41% of patients while the bottom 25% will prescribe antibiotics to less than 23% of patients. Inter-prescriber variation in antibiotic prescribing remained after adjustment for patient characteristics and CRP information (P < 0.001). CONCLUSIONS: Despite sharing the same management guidelines, there was substantial inter-prescriber variation in antibiotic prescription to patients with acute fever. This variation should be considered when designing trials and stewardship programmes aiming to reduce inappropriate antibiotic prescribing.
Authors: Thomas P Van Boeckel; Sumanth Gandra; Ashvin Ashok; Quentin Caudron; Bryan T Grenfell; Simon A Levin; Ramanan Laxminarayan Journal: Lancet Infect Dis Date: 2014-07-09 Impact factor: 25.071
Authors: Daniella Meeker; Jeffrey A Linder; Craig R Fox; Mark W Friedberg; Stephen D Persell; Noah J Goldstein; Tara K Knight; Joel W Hay; Jason N Doctor Journal: JAMA Date: 2016-02-09 Impact factor: 56.272
Authors: Rachel McKay; Allison Mah; Michael R Law; Kimberlyn McGrail; David M Patrick Journal: Antimicrob Agents Chemother Date: 2016-06-20 Impact factor: 5.191
Authors: Thomas Althaus; Rachel C Greer; Myo Maung Maung Swe; Joshua Cohen; Ni Ni Tun; James Heaton; Supalert Nedsuwan; Daranee Intralawan; Nithima Sumpradit; Sabine Dittrich; Zoë Doran; Naomi Waithira; Hlaing Myat Thu; Han Win; Janjira Thaipadungpanit; Prapaporn Srilohasin; Mavuto Mukaka; Pieter W Smit; Ern Nutcha Charoenboon; Marco Johannes Haenssgen; Tri Wangrangsimakul; Stuart Blacksell; Direk Limmathurotsakul; Nicholas Day; Frank Smithuis; Yoel Lubell Journal: Lancet Glob Health Date: 2019-01 Impact factor: 26.763
Authors: Arjun Chandna; Lisa J White; Tiengkham Pongvongsa; Mayfong Mayxay; Paul N Newton; Nicholas P J Day; Yoel Lubell Journal: Wellcome Open Res Date: 2019-08-05